enGene Therapeutics Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ENGN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
9
Funds holding
$6165686
Total value held
Buying
9 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ameriprise Financial Inc | $4629266 | 2675876 | +2675876 | NEW BUY |
| 2 | Ubs Group Ag | $880721 | 509087 | +509087 | NEW BUY |
| 3 | Barclays Plc | $488751 | 282515 | +282515 | NEW BUY |
| 4 | Morgan Stanley | $57239 | 33086 | +33086 | NEW BUY |
| 5 | Raymond James Financial Inc | $36946 | 21356 | +21356 | NEW BUY |
| 6 | Sei Investments Co | $32012 | 18504 | +18504 | NEW BUY |
| 7 | Royal Bank Of Canada | $20000 | 11325 | +11325 | NEW BUY |
| 8 | Wells Fargo & Company/Mn | $11833 | 6840 | +6840 | NEW BUY |
| 9 | Stonex Group Inc. | $8918 | 10371 | +10371 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.